Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships
Ojasvi Gupta, Tathagata Pradhan, Rohit Bhatia, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113606-113606
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

New quinoline-based triazole hybrid analogs as effective inhibitors of α-amylase and α-glucosidase: Preparation, in vitro evaluation, and molecular docking along with in silico studies
Yousaf Khan, Shahid Iqbal, Mazloom Shah, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 35
Molecular Docking and Molecular Dynamics Simulations in Related to Leishmania donovani: An Update and Literature Review
Mabel R. Challapa-Mamani, Eduardo Tomás-Alvarado, Angela Espinoza-Baigorria, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 10, pp. 457-457
Open Access | Times Cited: 19
The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115609-115609
Closed Access | Times Cited: 14
Synthetic product-based approach toward potential antileishmanial drug development
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115927-115927
Closed Access | Times Cited: 14
Antimicrobial Activity and DFT Studies of a Novel Set of Spiropyrrolidines Tethered with Thiochroman-4-one/Chroman-4-one Scaffolds
Nourhène Chouchène, Amani Toumi, Sarra Boudriga, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 582-582
Open Access | Times Cited: 24
Coumarins from Rutaceae: Chemical diversity and biological activities
Cezar Miguel Santos, Samara Machado Cardoso Silva, Edijane Matos Sales, et al.
Fitoterapia (2023) Vol. 168, pp. 105489-105489
Closed Access | Times Cited: 13
Selenium-Containing (Hetero)Aryl Hybrids as Potential Antileishmanial Drug Candidates: In Vitro Screening against L. amazonensis
Maria Helena Fermiano, Amarith R. das Neves, Fernanda da Silva, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 213-213
Open Access | Times Cited: 3
Evolution of the Quinoline Scaffold for the Treatment of Leishmaniasis: A Structural Perspective
Carlos F. M. Silva, Diana C. G. A. Pinto, Pedro Alexandrino Fernandes, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 285-285
Open Access | Times Cited: 3
Total Synthesis of the Natural Chalcone Lophirone E, Synthetic Studies toward Benzofuran and Indole-Based Analogues, and Investigation of Anti-Leishmanial Activity
Luca Pozzetti, Roberta Ibba, Sara Rossi, et al.
Molecules (2022) Vol. 27, Iss. 2, pp. 463-463
Open Access | Times Cited: 19
Modulating leishmanial pteridine metabolism machinery via some new coumarin-1,2,3-triazoles: Design, synthesis and computational studies
Nayera W. Hassan, Ahmed Sabt, Maryam A.Z. El-Attar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 253, pp. 115333-115333
Closed Access | Times Cited: 9
Isatin Conjugates as Antibacterial Agents: A Brief Review
Firoj Hassan, Iqbal Azad, Mohd Asif, et al.
Medicinal Chemistry (2022) Vol. 19, Iss. 5, pp. 413-430
Closed Access | Times Cited: 14
Prediction of Antileishmanial Compounds: General Model, Preparation, and Evaluation of 2-Acylpyrrole Derivatives
C. Santiago, Bernabé Ortega-Tenezaca, Iratxe Barbolla, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 16, pp. 3928-3940
Open Access | Times Cited: 11
Seleno-indoles trigger reactive oxygen species and mitochondrial dysfunction in Leishmania amazonensis
Paulo Santana Filho, Matheus Brasil da Silva, Bruna Nathália Malaquias da Silva, et al.
Tetrahedron (2023) Vol. 135, pp. 133329-133329
Closed Access | Times Cited: 5
Sojourn of Nitrogenous Heterocycles as Promising Antileishmanial Agents: Medicinal Perspectives and Structure–Activity Relationship Studies
Bhupender Nehra, Manoj Kumar, Sumitra Singh, et al.
Chemistry Africa (2024) Vol. 7, Iss. 7, pp. 3485-3529
Closed Access | Times Cited: 1
Design, Synthesis, and Biological Studies of C-5-Substituted Diazenyl Derivatives of Uracil as Potent and Selective Antileishmanial Agents Targeting Uridine Biosynthesis Pathway Enzymes
Tushar Das, Prakash Kumar, Sachin Kumar, et al.
ACS Infectious Diseases (2024)
Closed Access | Times Cited: 1
Unveiling a New Selenocyanate as a Multitarget Candidate with Anticancer, Antileishmanial and Antibacterial Potential
Sandra Ramos-Inza, Andreina Henriquez-Figuereo, Esther Moreno, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7477-7477
Open Access | Times Cited: 8
Design and synthesis of N-acyl and dimeric N-Arylpiperazine derivatives as potential antileishmanial agents
Shabina B. Ansari, Sakshi Kamboj, Ramalingam Karthik Raja, et al.
Bioorganic Chemistry (2023) Vol. 137, pp. 106593-106593
Closed Access | Times Cited: 3
High Selectivity of 8-Hydroxyquinoline on Leishmania (Leishmania) and Leishmania (Viannia) Species Correlates with a Potent Therapeutic Activity In Vivo
Sarah Kymberly Santos de Lima, Jéssica Adriana Jesus, Cristiano Raminelli, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 707-707
Open Access | Times Cited: 3
Novel Dual Acting Antimalarial Antileishmanial Agents Derived from Pyrazole Moiety
Adnan A. Bekhit, Sherry N. Nasralla, Salma A. Bekhit, et al.
Biointerface Research in Applied Chemistry (2021) Vol. 12, Iss. 5, pp. 6225-6233
Open Access | Times Cited: 8
DNA and BSA Interaction Studies and Antileukemic Evaluation of Polyaromatic Thiosemicarbazones and Their Copper Complexes
Giorgio Pelosi, Silvana Pinelli, Franco Bisceglie
Compounds (2022) Vol. 2, Iss. 2, pp. 144-162
Open Access | Times Cited: 5
5‐Arylidene‐2,4‐thiazolidinediones as Cysteine Protease Inhibitors against Leishmania Donovani
Sweta Sharma, Prasanna Anjaneyulu Yakkala, Mirza Beg, et al.
ChemistrySelect (2023) Vol. 8, Iss. 29
Closed Access | Times Cited: 2
Deciphering the mechanism of action of VP343, an antileishmanial drug candidate, in Leishmania infantum
Sameh Obeid, Eloísa Berbel Manaia, Valérie Nicolas, et al.
iScience (2023) Vol. 26, Iss. 11, pp. 108144-108144
Open Access | Times Cited: 2
Easy one-pot synthesis of multifunctionalized indole–pyrrole hybrids as a new class of antileishmanial agents
Vittorio Ciccone, Aurora Diotallevi, Miriam Gómez-Benmansour, et al.
RSC Advances (2024) Vol. 14, Iss. 22, pp. 15713-15720
Open Access
In vitro and in silico evaluation of the anti-leishmania activity of synthetic chalcones
Fernando Ferreira Leite, Luís Cézar Rodrigues, Bruno Hanrry Melo de Oliveira, et al.
Natural Product Research (2024), pp. 1-12
Closed Access
Harnessing computational and experimental approaches to identify potent hits against Leishmania donovani sterol C-24 methyltransferase from ChemBridge library
Diksha Kumari, Tashi Palmo, Somdutt Mujwar, et al.
Acta Tropica (2024) Vol. 260, pp. 107473-107473
Closed Access
Page 1 - Next Page

Scroll to top